Clinical Trial Update: A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy [Phase 2]

View source ↗

Summary

A Phase II trial evaluating adjuvant docetaxel in men at high risk of relapse following prostatectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED